controls in the Spanish cohort ( p=0.012, OR=1.18, CI 95% =1.04 to 1.34) and in the combined meta-analysis ( p=2.62×10 −3 , OR=1.20, CI 95%=1.06 to 1.35) including the Italian cohort (figure 1). Moreover, homozygous carriers of the allele C+ allele C (CC) genotype evidenced increased GCA risk in the combined data in comparison with non-CC carriers ( p=9.6×10 −3 , OR=1.29, CI 95%=1.07 to 1.55). Despite their different geographical origin, we previously reported no differences in the clinical spectrum of the disease between both populations, 8 and the combinability test according to Breslow-Day method showed no significant heterogeneity in the ORs. When cases were meta-analysed against controls according to the specific clinical features of GCA, only a significant association with visual ischaemic manifestations was observed ( p=0.014, OR=1.29, CI 95%=1.05 to 1.58). In addition, no statistically significant differences were observed when the subphenotype analysis was performed comparing GCA patients positive against those negative for the analysed clinical characteristic (data not shown).
This study shows for the first time that NLRP1 rs8182352, a polymorphism with no predicted functional role, is associated with GCA in two different European populations. It has been proposed that NLRP1 is an important regulator of different inflammatory and autoimmunity processes, mainly because of its ability to form the inflammasome that plays a pivotal role in the activation of IL-18 and IL-33. 4 Previous studies evidenced that IL-18, which is expressed by a wide range of immune cells and can mediate both Th1 and Th2 driven immune responses, contributes to the pathogenesis of GCA. 9 Furthermore, this vasculitis is associated with increased inflammatory response, 6 and IL-33 has been characterised as a critical component of the inflammatory disease, with immune cell activation. 10 In conclusion, we have identified NLRP1 as a novel GCA susceptibility gene, thus adding another piece to the genetic puzzle underlying the pathogenesis of this complex disease. Our data suggest that the inflammasome may represent a potential target for future therapeutic intervention. However, further studies may be performed to elucidate the possible causal variant/s of this association and its functional consequence, which is a limitation of this study. Sergio Prieto-González, 4 José A Miranda-Filloy, 5 Luis Rodríguez-Rodríguez, 6 Inmaculada C Morado, 6 Carmen Gomez-Vaquero, 7 Ricardo Blanco, 8 Bernardo Sopeña, 9 Norberto Ortego-Centeno, 
